Indian companies are gearing up to produce ingredients for generic weight-loss drugs. Novo Nordisk's patents are expiring soon. Dr Reddy's and Macleods are among the firms preparing. They aim to tap into a large global market. However, they will face competition from Chinese companies. Securing quality materials and scaling up production are key challenges.